• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.31% Nasdaq Up 0.16%

    Clovis Oncology, Inc. (CLVS)

    -NasdaqGS
    84.75 Down 1.13(1.31%) 9:39AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:85.88
    Open:N/A
    Bid:80.20 x 200
    Ask:91.59 x 500
    1y Target Est:107.29
    Beta:1.47
    Next Earnings Date: 3-Aug-15CLVS Earnings announcement
    Day's Range:84.73 - 85.93
    52wk Range:35.33 - 102.28
    Volume:9,374
    Avg Vol (3m):783,383
    Market Cap:2.89B
    P/E (ttm):N/A
    EPS (ttm):-5.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLVS

    Comparison

    Symbol% ChgMkt Cap
    CLVSDown 1.31%2.89B
    IMMU 0.00%369.18M
    LRUSF 0.00%N/A
    THLD 0.00%277.49M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-8.48
    Quarterly EPS Est (Jun-15) :-1.99
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback